ArticleGynecology and pelvic medicine2025

Novel combination of immunotherapy and tyrosine kinase inhibitor for recurrent cervical cancer: balancing efficacy and toxicity.

Soraya Sánchez-Molero Pérez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.